|
 |
Epoetin alfaThis page contains recent news articles, when available, and an overview of Epoetin alfa but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Epoetin alfa (when available) Used in the treatment of anemia. Involved in the regulation of erythrocyte differentiation and the maintenance of a physiological level of circulating erythrocyte mass. For treatment of anemia (from renal transplants or certain HIV treatment) Mechanism Of Action: Binding of erythropoietin to the erythropoietin receptor leads to receptor dimerization, which facilitates activation of JAK-STAT signaling pathways within the cytosol. Activated STAT (signal transducers and activators of transcription) proteins are then translocated to the nucleus where they serve as transcription factors which regulate the activation of specific genes involved in cell division or differentiation. News Articles on Epoetin alfa Impact of Epoetin-beta on Survival and Tumor Progression Affected by Starting ... - 05 Jan 2010 The most commonly used ESAs in the United States are Epogen® (epoetin alfa) Aranesp® (darbebpoetin). The most commonly use ESA in Europe is epoetin-beta ... Cancer Consultants Bypass Anemia Drugs in Chronic Kidney Disease, Expert Says - Dec 24, 2009 In CHOIR, epoetin-alfa (Procrit) targeted to a hemoglobin of 13.5 g/dl raised the composite rate of death, MI, heart failure, hospitalization, and stroke by ... MedPage Today Tired of Being Tired?Cancer-related fatigue doesn't have to slow you down. - Dec 23, 2009 ...available at www.curetoday.com/new_blood), but erythropoiesis-stimulating agents, such as Procrit (epoetin alfa) and Aranesp (darbepoetin alfa), ... Curetoday.com (press release) A New Look at High Hb Goals - Dec 10, 2009 ...a randomized trial comparing the effect of treatment with epoetin alfa to two Hb targets (11.3 and 13.5 g/L) on the composite end point of death, ... Renal and Urology News A vörösvértest-termelés serkentése hátrányos lehet - Dec 28, 2009 Az epoetin-alfa hatására magasabb lett a halálozási arány, gyakoribb lett a szÃvinfarktus, a szÃvelégtelenség, és többször volt szükség a betegek kórházba ... medicalonline.hu/ ë‚´ë…„ ì œì•½ì‹œìž¥ 치료계열별 íŒ?ë?„ ì°¨ì?´ - Dec 9, 2009 ...보존치료 분야ì—?ì„ 'ì•„ë?¼ë„¤ìŠ¤í”„'와 '프로í?¬ë¦¬íŠ¸'(Procrit, epoetin alfa)는 ì•ˆì „ì„± ë¬¸ì œë¡œ 매출ì?´ ë–¨ì–´ì§€ê² ì§€ë§Œ '뉴í?¬ê²?'(Neupogen, filgrastim)ê³¼ '뉴ë?¼ ... 디지틀보사 Aranesp, Epogen and Procrit Blood Clot Risk Confirmed: Study - Nov 11, 2009 Amgen's Aranesp (darbepoetin alfa) and Epogen (Epoetin alfa) and Johnson and Johnson's Procrit (Epoetin alfa) are prescribed to patients with kidney disease ... AboutLawsuits.com ASN: Major Anemia Trial Results Lead to Practice Changes - Nov 3, 2009 The findings led the FDA to add to the labels of the ESAs epoetin-alfa (Epogen, Procrit) and darbepoetin alfa (Aranesp) a boxed warning against aggressively ... MedPage Today Program Found to Improve Cancer-Related Insomnia However, second study finds ... - Nov 5, 2009 5 (HealthDay News) -- Cancer-related insomnia can be improved by behavioral therapy but not epoetin alfa, according to two studies published online Nov. ... ModernMedicine Anemia Drug May Raise Stroke Risk in Kidney Patients - Oct 31, 2009 In earlier studies, Aranesp and a similar drug, epoetin alfa, marketed as Procrit or Epogen, were linked to increased risk of death in cancer and stroke ... U.S. News & World Report Comparing ESA Dosing Regimens for Anemic Kidney Disease Patients - Oct 21, 2009 Although the FDA-approved starting dose of epoetin alfa for the correction of anemia in patients with chronic kidney disease (CKD) is 50-100 IU/kg, ... National Anemia Action Council Affymax and Takeda Announce Hematide Publication in the New England Journal of ... - Nov 4, 2009 ...human erythropoietins, such as epoetin alfa or beta and darbepoetin alfa, thus suppressing the production of red blood cells by the bone marrow. ... Reuters Risks outweighed benefits of darbepoetin alfa in patients with type 2 diabetes ... - Nov 3, 2009 ...and Outcomes in Renal Insufficiency (CHOIR) trial, which studied the use of epoetin alfa treatment to achieve two different target hemoglobin levels. ... Endocrine Today Affymax and Takeda Announce Preliminary Phase 2 Data Demonstrated That ... - Oct 30, 2009 This is the first reported data from an open-label, controlled comparative study of once-monthly Hematide compared to three times per week epoetin alfa ... Reuters Why Large Doses of IV Iron Decrease HD Patient Survival Is Unclear - Nov 1, 2009 These patients were much more likely to have received very high doses of epoetin alfa. The researchers ruled out underlying bleeding conditions that ... Renal and Urology News Outlining Drug-Induced Anemia and Select Medications - Oct 21, 2009 Several studies have found that these drugs do not affect the action of epoetin alfa, and that doses and Hb levels are similar among treated and control ... National Anemia Action Council Amgen profit rises, shares decline - Oct 22, 2009 Sales of Epogen (Epoetin alfa) increased 5% to $663 million in the third quarter of 2009 due to an increase in demand primarily from patient population ... NephrOnline Amgen: Prolia delay further dampens expectations of hyped drug - Oct 20, 2009 The US biotech has been facing a continuous decline in sales of its leading products Aranesp (darbepoetin alfa) and Epogen (epoetin alfa) and is relying on ... Trading Markets (press release) Band-Aid Won't Stop Generic Bleeding at Johnson & Johnson - Nov 11, 2009 More worrisome, the workhorse drug Procrit (epoetin alfa) is starting to look like its got a stone embedded in one hoof: this biologic, an injectable ... BNET Amgen's Third Quarter 2009 Adjusted Earnings Per Share Increased 21 Percent to ... - Oct 21, 2009 Sales of EPOGEN(®) (Epoetin alfa) increased 5 percent to $663 million in the third quarter of 2009 versus $634 million in the third quarter of 2008 due to ... Reuters Phase 2 trail data shows Hematide increases haemoglobin & reduces blood ... - Nov 8, 2009 ...human erythropoietins, such as epoetin alfa or beta and darbepoetin alfa, thus suppressing the production of red blood cells by the bone marrow. ... pharmabiz.com Heart Failure, Diabetes Attentuate Risk of High Hemoglobin - Oct 30, 2009 CHOIR is a randomized trial comparing the effect of treatment with epoetin alfa to two hemoglobin targets (11.3 and 13.5 g/L) on the composite end point of ... Renal and Urology News Amgen 3Q Profit Up 24% - Oct 22, 2009 ...(Epoetin alfa) increased 5 percent to $663 million in the third quarter of 2009 versus $634 million in the third quarter of 2008 due to an increase in ... The FINANCIAL Epo-Präparat erhöht Schlaganfallrisiko - Nov 2, 2009 Dort hatte der Versuch, die Ergebnisse einer Thrombolyse durch die Gabe von Epoetin alfa zu verbessern, mit einem Anstieg der Todesfälle (16 vs. ... Deutsches Ärzteblatt Novartis' Sandoz unit gains EU approval for biosimilar epoetin alfa - Aug 31, 2007 ZURICH (Thomson Financial) - Novartis AG said its Sandoz unit has received European Commission approval for biosimilar epoetin alfa, for the treatment of ... Forbes Anemia Drugs Linked to Stroke Study Deaths: FDA - Sep 25, 2008 The new German study looked at the use of epoetin alfa as an aid to stroke recovery. "These drugs are not licensed in the United States for this particular ... Forbes Novartis clears EU hurdle for generic biotech drug - Jun 22, 2007 Epoetin alfa is marketed in Europe by Johnson & Johnson under the brand name Eprex, ... Epoetin alfa, for example, was approved by the FDA in 1989. ... MarketWatch Ortho, Amgen Tout Anemia Drugs - May 15, 2005 Meanwhile, Amgen countered with data saying the final results of a study found that Aranesp administered every two weeks is as effective as epoetin alfa ... TheStreet.com - TheStreet.com (subscription) FDA Reviewing Deaths in Anemia Drug Study - Sep 27, 2008 Eprex is known generically as epoetin alfa. Johnson & Johnson also sells epoetin alfa under the name Procrit. Amgen sells a version under the name Epogen. ... New York Times Learn about Epoetin Alfa Injection from Consumer Reports Health. - Jan 9, 2008 All patients: Epoetin alfa increases the risk of blood clots forming in or moving to the ... Full Alert. Pending revision, the material in this section ... consumerreports.org Sandoz Receives Positive EU Opinion For Approval Of Epoetin Alfa … - Jun 24, 2007 The CHMP recommendation supports the use of epoetin alfa for indications ... There can be no guarantee that epoetin alfa will be approved for sale in the EU ... Medical News Today - Medical News Today (press release) Study Of Aranesp(R) Dosed Every Two Weeks Versus Epoetin Alfa Dosed … - May 22, 2006 In this study, the safety profile for both Aranesp and Epoetin alfa was consistent with the existing clinical experience for adverse events in anemic cancer ... Medical News Today - Medical News Today (press release) … Patients Treated With PROCRIT(R) (Epoetin Alfa) Once Every Three … - Dec 9, 2006 Shasha, D., Dawkins, F., Wilhelm, F. "Epoetin alfa 80000 U Every Three Weeks (Q3W) in Anemic Cancer Patients Not Receiving Chemotherapy or Radiation Therapy ... Medical News Today - Medical News Today (press release) … (R) Data Confirm Equivalent Efficacy To Epoetin Alfa In Renal... - Sep 8, 2008 Principal investigator of all three analyses, Professor Paul Scigalla of International Clinical Research Consulting (ICRC), commented, "These new data give ... Medical News Today - Medical News Today (press release) PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of... - Dec 6, 2007 ATLANTA, Dec. 6 /PRNewswire/ -- Data from 11 PROCRIT(R) (Epoetin alfa) studies will be presented at the American Society of Hematology (ASH) 49th Annual ... Free with registration - PR Newswire - AccessMyLibrary.com German Trial Reports 42 Deaths in Epoetin Alfa Stroke Study - Sep 19, 2008 By Donna Young. The anemia drug epoetin alfa has been linked to 42 deaths in patients participating in a German clinical trial testing the drug's use as a ... BioWorld Online - BioWorld Online High-Dose Epoetin Alfa (Procrit) Every 3 Weeks Effective for … - Dec 14, 2005 By Bruce Sylvester. ATLANTA, GA -- December 14, 2005 -- Epoetin alfa (Procrit) 80000 units administered every 3 weeks to patients on an every-3-week ... DG News Treatment of Anemia in Chronic Kidney Disease - Dec 21, 2006 The transition from epoetin alfa to darbepoetin alfa therapy is usually uncomplicated. The approximate conversion is 200 IU of epoetin alfa to 1 mcg of ... Medscape Controversial Anemia Drug Doesn't Cut Need for Transfusions - Sep 5, 2007 The drug, epoetin alfa (brand names Epogen and Procrit) has been under ... The study authors hypothesized that giving epoetin alfa would reduce the need for ... Washington Post Cancer Therapy; Cost of epoetin alfa and darbepoetin alfa treatment... - Nov 22, 2005 2005 NOV 22 - (NewsRx.com) -- The cost of using epoetin alfa and darbepoetin alfa for treatment of chemotherapy-related anemia in cancer patients in Sweden ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones … Biotech Modifies Prescribing Information for PROCRIT® (Epoetin... - Mar 11, 2008 Ortho Biotech Products, LP today modified prescribing information for PROCRIT® (Epoetin alfa), following guidance from the US Food and Drug Administration ... webwire.com … Committee probes EPO use, dialysis costs.(epoetin alfa)(Congress... - Dec 11, 2006 The drugs, mostly Amgen Inc.'s Epogen (epoetin alfa) and to a lesser extent Aranesp (darbepoetin alfa), represent CMS' largest drug expense. Pay-Per-View - BioWorld Week - Factiva, from Dow Jones Black Box Warning Ordered for Aranesp, Epogen, and Procrit - Mar 9, 2007 Patients treated before surgery with epoetin alfa to reduce allogenic red ... The epoetin alfa dose was titrated to maintain a hemoglobin level of 12 to 14 ... MedPage Today Extended dosing of darbepoetin alfa article: corrections.(Correction ... - Nov 1, 2005 Exceptions to this requirement are epoetin alfa and darbepoetin alfa. Drugs may be categorized into 1) drugs included in the composite rate but not ... Pay-Per-View - Nephrology Nursing Journal - HighBeam Research Continuous Erythropoietin Receptor Activator Anti-Anemia Drug … - Jul 17, 2006 These included two studies using epoetin alfa/beta as a comparator and one study using darbepoetin alfa. (1,2,4). "This was the first phase 3 study for its ... DG News … Requires Fewer Dosing Changes Than Epoetin Alfa: Presented at ASN - Nov 8, 2008 PHILADELPHIA -- November 8, 2008 -- Twice-monthly intravenous darbepoetin alfa requires fewer changes in dose than does epoetin alfa, causing less ... DG News … for PROCRIT(R) (Epoetin alfa) Label Reflects Recommendations from - Nov 8, 2007 8 /PRNewswire-FirstCall/ -- Ortho Biotech Products, LP today modified prescribing information for PROCRIT(R) (Epoetin alfa), following guidance from the US ... Free with registration - PR Newswire - AccessMyLibrary.com Meta-analysis evaluates the effect of epoetin alfa on left ventricular... - Jul 1, 2005 Researchers postulated epoetin alfa may provide survival benefits and amelioration of anemia and LVH based on the findings of a meta-analysis conducted ... National Anemia Action Council … Cost Considerations for PROCRIT(R) (Epoetin Alfa) and Darbepoetin... - Oct 26, 2006 A total of 25645 hospitalizations for patients with cancer were analyzed (Epoetin alfa: 22873; darbepoetin alfa: 2772), and 66822 hospitalizations for ... RedOrbit Single Lot of Epoetin Alfa Recalled Due to Damaged Vials - Aug 6, 2008 BRIDGEWATER, NJ -- August 6, 2008 -- Ortho Biotech is announcing that it is voluntarily recalling 1 manufacturing lot (P114942A) of Epoetin alfa (Procrit) ... DG News PROCRIT(R) (Epoetin Alfa) Data to Be Presented at American Society of... - Nov 1, 2007 SAN FRANCISCO, Nov. 1 /PRNewswire/ -- Data from six studies of PROCRIT(R) (Epoetin alfa) will be presented at the 40th annual meeting of the American ... Free with registration - PR Newswire - AccessMyLibrary.com Final Results of a Phase 3 European Study Demonstrate Aranesp(R) … - Jun 6, 2005 Amgen revolutionized Anaemia treatment with the development of recombinant erythropoietin, Epoetin alfa. Building on this heritage, Amgen developed Aranesp, ... presseportal.de … in the prescribing information for Epoetin alfa: implications for... - Mar 1, 2008 Revisions in the prescribing information for Epoetin alfa: implications for ... Epoetin alfa (EPOGEN[R]) revolutionized the treatment of anemia and has been ... Pay-Per-View - Nephrology Nursing Journal - HighBeam Research … ; Platinum-treated ovarian cancer patients managed with epoetin... - Jun 12, 2006 Patients were randomised 2:1 to receive epoetin alfa 10000-20000 IU three ... For the epoetin alfa group, mean Hb increased by 1.8 g/dl by weeks 4-6 and was ... Pay-Per-View - OBGYN & Reproduction Week - Factiva, from Dow Jones Press Release: Updated Analysis of 2001 Epoetin Alfa Study Posted. -... - Dec 5, 2007 Updated Analysis of 2001 Epoetin Alfa Study Posted. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research … Aranesp dosed every two weeks is comparable to Epoetin alfa dosed ... - May 16, 2005 ..."This is the largest, randomized head-to-head comparison of darbepoetin alfa dosed every two weeks to Epoetin alfa dosed weekly, as they are most often used ... PsychCentral.com Randomized Comparison of Epoetin Alfa (40,000 U Weekly) and … - Apr 3, 2006 This biased trial does nothing to advance therapeutics in this important area of supportive care. What physicians, patients, insurers want out of these two ... Gerson Lehrman Group Press Release: PROCRIT(R) (Epoetin Alfa) Data to be Presented at … - Dec 6, 2007 PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research EU Panel Backs Wider Approval Of Merck's Erbitux - Oct 24, 2008 KG, and Epoetin Alfa Hexal (epoetin alfa), from Hexal Biotech Forschungs GmbH, ... Binocrit, Abseamed and Epoetin Alfa Hexal are currently indicated in the ... Capital.gr Chemotherapy; Epoetin alfa for treatment of cancer-related anemia … - Apr 25, 2005 2005 APR 25 - (NewsRx.com) -- A researcher reviews epoetin alfa for the treatment of cancer-related anemia in a recent issue of Expert Opinion on ... Pay-Per-View - Clinical Trials Week - Factiva, from Dow Jones Study Explores Use Of PROCRIT(R) (Epoetin Alfa) Once Every Two … - Jun 4, 2006 New study results presented today suggest that 80000 units of PROCRIT(R) (Epoetin alfa) administered once every two weeks demonstrated comparable changes in ... Medical News Today - Medical News Today (press release) Revised labeling for epoetin alfa (Procrit, Ortho Biotech) was issued... - Jan 1, 2005 Revised labeling for epoetin alfa (Procrit, Ortho Biotech) was issued advising dosing interruption and modification with patients in whom the rate of rise ... Free with registration - Formulary - AccessMyLibrary.com Epoetin Alfa Effectively Controls Hemoglobin in Clinical Practice - Apr 23, 2007 April 23, 2007 — Using actual US practice patterns and dosing, epoetin alfa (Epogen; peg-EPO therapy) effectively maintains hemoglobin (Hb) levels in ... Medscape … Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin... - Mar 8, 2008 Depending on the country in which Epoetin alfa is marketed, these indications may differ. Renal failure: Patients experienced greater risks for death and ... Free with registration - PR Newswire - AccessMyLibrary.com First large study of epoetin alfa in children with cancer for anemia,... - Oct 1, 2006 In a large, 16 week, randomized, placebo controlled study (N=222), epoetin alfa (EPO) was given to children with non-myeloid malignancies receiving ... National Anemia Action Council Chemotherapy; Epoetin alfa for treatment of cancer-related anemia … - Apr 29, 2005 2005 APR 29 - (NewsRx.com) -- A researcher reviews epoetin alfa for the treatment of cancer-related anemia in a recent issue of Expert Opinion on ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Retacrit equivalent to epoetin alfa - Sep 9, 2008 New data showing Retacrit corrects low haemoglobin (Hb) levels as effectively and rapidly as epoetin alfa in patients with chronic kidney disease, ... Pharmacy Europe … Receives European Commission Approval for biosimilar epoetin alfa - Sep 3, 2007 This approval was indicated for the use of biosimilar epoetin alfa in treating patients with renal anemia as well as those receiving chemotherapy. ... webwire.com Erythropoietin claims monitoring policy: implications for clinical... - Mar 1, 2006 When Medicare first approved reimbursement for Epoetin alfa in 1989, ... This led to low doses of Epoetin alfa and a minimal impact on outcomes. ... Pay-Per-View - Nephrology Nursing Journal - HighBeam Research Extended dosing of darbepoetin alfa in patients with chronic kidney … - Jul 1, 2005 Two ESPs are currently available to treat anemia in patients with CKD: recombinant human erythropoietin (rHuEPO; Epoetin alfa) and darbepoetin alfa ... $4.95 - Nephrology Nursing Journal - ECNext … Investigational Use Of PROCRIT® (Epoetin Alfa) Presented At... - Nov 8, 2008 Data from an investigational, open-label, randomized study assessing extended dosing regimens of PROCRIT® (Epoetin alfa) in treating anemia in subjects with ... Medical News Today - Medical News Today (press release) … Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and... - Sep 11, 2007 Depending on the country in which Epoetin alfa is marketed, these indications may differ. Important US Safety Information for PROCRIT From the Boxed ... Free with registration - PR Newswire - AccessMyLibrary.com Darbepoetin Alfa and Epoetin Alfa Use in Hospitals to Combat Anemia … - Oct 26, 2006 By Ed Susman. SALT LAKE CITY, UT -- October 26, 2006 -- The use of erythropoiesis-stimulating protein products among hospitalized surgical patients to ... DG News Extended dosing of darbepoetin alfa in patients with chronic kidney … - Jul 1, 2005 Two ESPs are currently available to treat anemia in patients with CKD: recombinant human erythropoietin (rHuEPO; Epoetin alfa) and darbepoetin alfa ... Pay-Per-View - Nephrology Nursing Journal - HighBeam Research FDA issues safety alerts for two cancer treatments and epoetin alfa - Sep 26, 2008 This week, the FDA released MedWatch alerts regarding the safety of three oncologic therapeutic agents. Chromic Phosphate P 32, erlotinib and epoetin alfa ... HemOncToday Extended Epoetin Alfa Dosing Effects Similar in Diabetics - Aug 1, 2007 PATIENTS WITH and without diabetes respond similarly to extended dosing of epoetin alfa as infrequently as once every four weeks, data show. ... Renal and Urology News Fresenius Medical Care Announces New Sourcing and Supply … - Oct 19, 2006 EPOGEN[R] (Epoetin alfa) is a recombinant protein with the same mechanism of action as endogenous human erythropoietin, a protein produced by the kidneys to ... Free with registration - Business Wire - AccessMyLibrary.com Press Release: Research and Markets : Key process patents for … - May 3, 2005 Common conditions known to affect the response to Epoetin alfa include chronic or ... Abstract Objective: We sought to evaluate epoetin alfa drug costs in ... Pay-Per-View - M2 Presswire - HighBeam Research … Investigational Use of PROCRIT(R) (Epoetin Alfa) Presented at... - Nov 7, 2008 Depending on the country in which Epoetin alfa is marketed, ... Perisurgery: PROCRIT (Epoetin alfa) increased the rate of deep venous thromboses in patients ... RedOrbit ALFA International Corp acquires Journey of Light Inc - Deal Snapshot... - Jan 3, 2007 ...units of Procrit (Epoetin alfa) administered once every two weeks…an exte nded initiation dose of Epoetin alfa in this patient population, was… ... Pay-Per-View - deals - Alacra Store 2006 NBA Champion Alonzo Mourning Raises Awareness About Kidney … - Jul 6, 2006 PROCRIT(R) (Epoetin alfa) helps treat anemia by increasing the number of red blood ... PROCRIT(R) (Epoetin alfa) is for the treatment of anemia in chronic ... Free with registration - PR Newswire - AccessMyLibrary.com Iron deficiency in non-dialysis chronic kidney disease - Jun 18, 2008 Treatment was initiated with epoetin alfa 10000 U/week in the month of ... The dose of epoetin alfa was raised per protocol to 20000 U/week (Figure 1). ... Nature.com Phase 3 Trial Starts to Evaluate the Impact of Treating Anemia with … - Sep 6, 2005 Amgen revolutionized anemia treatment with the development of a recombinant erythropoietin, epoetin alfa, which is currently marketed in the US by Amgen as ... Medical News Today - Medical News Today (press release) ASN: Extended Dosing of Epoetin Alfa Appears Effective for Anemia in ... - Nov 7, 2008 By Todd Neale, Staff Writer, MedPage Today. PHILADELPHIA, Nov. 7 -- In chronic kidney disease, two extended dosing regimens of epoetin alfa (Procrit) worked ... MedPage Today Press Release: PROCRIT(R) (Epoetin Alfa) Data to Be Presented at … - Nov 1, 2007 PROCRIT(R) (Epoetin Alfa) Data to Be Presented at American Society of Nephrology Annual Meeting. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research … Biotech Revises Prescribing Information for PROCRIT(R) (Epoetin... - Mar 9, 2007 Located in Bridgewater, NJ, Ortho Biotech is an established market leader in Epoetin alfa therapy for anemia management. The company also markets treatments ... Free with registration - PR Newswire - AccessMyLibrary.com … Biotech Revises Prescribing Information For PROCRIT® (Epoetin Alfa) - Mar 12, 2007 Ortho Biotech Products, LP, today revised the label for PROCRIT® (Epoetin alfa), acting upon guidance from the US Food and Drug Administration (FDA) to ... Medical News Today - Medical News Today (press release) Epoetin Alfa in Critically Ill Patients - Oct 26, 2007 Anemia is a common acquired condition in critically ill patients, with 37% to 44% of patients requiring transfusion during their stay in the intensive care ... Medscape … and proactive adjustments to minimize the need for holding epoetin... - Nov 1, 2008 ...find Nephrology Nursing Journal articles. Patients who are on dialysis and receiving epoetin alfa (Epogen [R]) typically experience varying hemoglobin ... Pay-Per-View - Nephrology Nursing Journal - HighBeam Research … Patients Treated With PROCRIT(R) (Epoetin Alfa) Once Every Three … - Dec 8, 2006 8 /PRNewswire/ -- New investigational study results report that 80000 units of PROCRIT(R) (Epoetin alfa) administered once every three weeks may increase ... Genetic Engineering News - Genetic Engineering News (press release) Preliminary Data From Experimental Study Demonstrate Increased … - Sep 17, 2008 Epoetin alfa is marketed as EPREX(R) / ERYPO(R) outside the US by ... Epoetin alfa is a member of the class of erythropoiesis-stimulating agents (ESAs). ... RedOrbit … Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and... - Sep 11, 2007 Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Article: Route of administration for erythropoiesis-stimulating... - Sep 1, 2007 ...find Nephrology Nursing Journal articles. EPoetin alfa is typically administered by the intravenous (IV) route for patients on hemodialysis and by the ... Pay-Per-View - Nephrology Nursing Journal - HighBeam Research Article: Frequent assessment of longitudinal laboratory trends: a key... - Jul 1, 2007 Article: Conversion from epoetin alfa to darbepoetin alfa ... ... At this point ... same principles apply when the epoetin alfa dose is adjusted during ... Pay-Per-View - Nephrology Nursing Journal - HighBeam Research Chronic Hemodialysis; Darbepoetin alfa treatment is safe and cost- … - Sep 13, 2005 ..."After a recommendation from the manufacturer of epoetin alfa - that, where indicated for renal failure, epoetin alfa should be given intravenously - we ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Amgen vs. Roche: patent trial to kick off - Aug 29, 2007 Currently used epoetin therapies (epoetin alfa or beta) are administered one to three times weekly. The drug is already available in Austria, ... In-PharmaTechnologist.com SCCM: Epoetin Alfa Reduces Death Risk For Critically Ill Trauma... - Feb 19, 2007 By Michael Smith, Senior Staff Writer, MedPage Today. ORLANDO, Feb. 19 -- In critically ill trauma patients, recombinant epoetin alfa reduces mortality by ... MedPage Today Analysis of: Correction of Anemia with Epoetin Alfa in Chronic Kidney... - Nov 16, 2006 Erythropoietin (epo), whether Ortho's, Johnson & Johnson or by inference Amgen's Aranesp, can actually increase hemoglobin too much when administered to ... Gerson Lehrman Group Erythropoietin Claims Monitoring Policy: Implications of the 2006... - Nov 1, 2006 The new guideline limits the cumulative monthly Epoetin alfa dose to ... In acknowledgement of variability in response to Epoetin alfa, CMS will not require ... Free with registration - Nephrology Nursing Journal - AccessMyLibrary.com … Regimens of PROCRIT(R) (Epoetin alfa) as Maintenance Treatment fo - Aug 11, 2005 PROCRIT(R) (Epoetin alfa) is a prescription medication for the treatment of anemia in chronic kidney disease patients who are not on dialysis and is ... $4.95 - PR Newswire - ECNext … Nationwide Voluntary Recall of Procrit(R) (Epoetin Alfa) Lot Number... - Aug 5, 2008 Ortho Biotech markets and distributes Epoetin alfa under the tradename . ... Article: FDA expands Epoetin alfa use to include AIDS ... ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Preliminary Data From Experimental Study Demonstrate … - Sep 17, 2008 Epoetin alfa is marketed as EPREX(R) / ERYPO(R) outside the U.S. by ... Epoetin alfa is a member of the class of erythropoiesis-stimulating agents (ESAs). ... Pay-Per-View - PR Newswire - HighBeam Research Epoetin boosts quality of life in HIV patients.(Infectious Diseases)... - Feb 1, 2005 ...find Internal Medicine News articles. WASHINGTON -- Treatment with 1 dose of epoetin alfa every other week maintained a normal hemoglobin level and... Pay-Per-View - Internal Medicine News - HighBeam Research Frequent assessment of longitudinal laboratory trends: a key to … - Jul 1, 2007 Hb assessments and Epoetin alfa dosing practices were recorded at individual ... Trends in Hb levels in conjunction with a history of Epoetin alfa dose ... Free with registration - Nephrology Nursing Journal - AccessMyLibrary.com Correction of Anemia to Higher Hb Levels Increases Adverse Outcome … - Jan 1, 2007 Use of recombinant human erythropoietin (epoetin alfa) is indicated for the ... Further, a cost benefit of using less epoetin alfa should be considered. ... National Anemia Action Council FDA warns over deaths in German epoetin alfa stroke trial; further... - Oct 6, 2008 FDA warns over deaths in German epoetin alfa stroke trial; further woes for J&J. The US Food and Drug Administration has issued an early warning regarding ... $9.94 - Pharma Marketletter - Alacra Store … Information for PROCRIT(R) (Epoetin alfa). - PR Newswire | Hig - Mar 9, 2007 About PROCRIT (Epoetin alfa). Read all of this article with a FREE trial. COPYRIGHT 2007 PR Newswire Association LLC. This material is published under ... Pay-Per-View - PR Newswire - HighBeam Research Aranesp, Procrit, Epogen Linked to Risks of Pure Red Cell Aplasia, … - Dec 2, 2005 Darbepoetin alfa and epoetin alfa are indicated for the treatment of CRF-related anemia, and chemotherapy-related anemia in patients with nonmyeloid ... Medscape Cost-Minimization Analysis of Darbepoetin Alpha vs Epoetin Alpha - Jan 3, 2006 Purpose: The cost of darbepoetin alfa versus that of epoetin alfa in a hospital setting ... Epoetin alfa is the genetically engineered form of endogenous ... Medscape Chemotherapy; Early efficacy of epoetin alfa superior to darbepoetin... - Nov 22, 2005 2005 NOV 22 - (NewsRx.com) -- Epoetin alfa (EPO) is more likely than darbepoetin alfa (DARB) to produce an early response in patients with ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones … Information for PROCRIT(R) (Epoetin alfa). - PR Newswire | Hi - Mar 8, 2008 Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa). from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Press Release: Research and Markets: Key Process Patents for … - May 3, 2005 Article: FDA expands Epoetin alfa use to include AIDS . ... Experience Clinical trials of Epoetin alfa were begun by Amgen in late ... doses of recombinant ... Pay-Per-View - PR Newswire - HighBeam Research … R) Dosed Every Two Weeks versus Epoetin Alfa Dosed Weekly Published... - May 18, 2006 In this study, the safety profile for both Aranesp and Epoetin alfa was consistent with the existing clinical experience for adverse events in anemic cancer ... Genetic Engineering News - Genetic Engineering News (press release) Article: Stop ESAs in nonresponders after 6-8 weeks.(Hematology)( … - Jan 1, 2008 Article: Conversion from epoetin alfa to darbepoetin alfa ... ... Epoetin alfa may be converted to darbepoetin alfa based on the weekly dose of epoetin ... ... Pay-Per-View - Internal Medicine News - HighBeam Research … : Study Explores Use of PROCRIT(R) (Epoetin Alfa) Once Every Two … - Jun 3, 2006 Study Explores Use of PROCRIT(R) (Epoetin Alfa) Once Every Two Weeks As Initiation Treatment for Chemotherapy-Related Anemia. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research … Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at... - Nov 7, 2008 Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research … of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and ... - Mar 11, 2008 Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced ... Pay-Per-View - PR Newswire - HighBeam Research Abstract and Introduction - Nov 26, 2007 Objectives: To evaluate the effect of epoetin alfa treatment on hemoglobin ... Intervention: Subcutaneous epoetin alfa or placebo weekly for 16 weeks (Phase ... Medscape … -World Dosing and Cost Considerations for PROCRIT(R) (Epoetin Alfa)... - Oct 26, 2006 About PROCRIT (Epoetin alfa) PROCRIT is used for the treatment ... chemotherapy ... Article: PROCRIT(R) (Epoetin Alfa) Data to Be Presented at American ... ... Pay-Per-View - PR Newswire - HighBeam Research Pure red cell aplasia due to follow-on epoetin - Jun 11, 2008 Correspondence: AK Singh, Renal Division, Department of Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, Massachusetts 02115, USA. ... Nature.com Treating Anemia Improves Fatigue and Quality of Life in Elderly: … - May 11, 2006 Epoetin alfa treatment was well tolerated, Dr. Agnihotri said. ... Nine of these events occurred during epoetin alfa treatment and 18 during placebo ... DG News FDA has requested that a boxed warning be added to the prescribing … - Apr 1, 2007 Amgen) and epoetin alfa (Epogen, Amgen; Procrit, Ortho Biotech). ... and cautions that patients treated preoperatively with epoetin alfa to reduce ... Free with registration - Formulary - AccessMyLibrary.com Refractory anemia in a patient with allergy to intravenous iron drugs - Apr 19, 2006 The weekly epoetin alfa dose had progressively been increased; most recently, ... Other potential causes of epoetin alfa resistance had been studied, ... Nature.com FDA Safety Labeling Changes: Aranesp, Avastin, Intron A - Apr 6, 2005 In addition, results of a one-year randomized trial involving 939 patients with breast cancer showed that epoetin alfa therapy was associated with a higher ... Medscape Brand Names/Synonyms: Epoetin alfa is also known by the following brand names and/or synonymsErythropoietin precursor;Epoetin; Epogen (Amgen Inc.); Epogin (Chugai); Epomax (Elanex); Eprex (Janssen-Cilag. Ortho Biologics LLC); NeoRecormon (Roche); Recormon (Roche); Procrit (Ortho Biotech) Drug Category: Epoetin alfa is categorized under the following by the FDA: Antianemic Agents; hematopoietic agents (20:16.00) Dosage Forms: SOLUTION Absorption: Not Available Interactions: Not Available Chemical IUPAC Name: Human erythropoietin |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |